Tumor associated antigen vaccine enhances anti-tumor effects of immune checkpoint inhibitors against refractory cancers.

被引：0

作者：

Ueda, Shohei ^{[1
]}

Ushijima, Miho ^{[1
]}

Irie, Atsushi ^{[2
]}

Senju, Satoru ^{[2
]}

Ito, Koyu ^{[3
]}

Hamana, Hiroshi ^{[4
]}

Kishi, Hiroyuki ^{[5
]}

Ogasawara, Koetsu ^{[3
]}

Udaka, Keiko ^{[6
]}

Eto, Masatoshi ^{[1
]}

Nishimura, Yasuharu ^{[2
]}

机构：

[1] Kyushu Univ, Grad Sch Med Sci, Dept Urol, Fukuoka, Fukuoka, Japan

[2] Kumamoto Univ, Grad Sch Med Sci, Dept Immunogenet, Kumamoto, Japan

[3] Tohoku Univ, Inst Dev Aging & Canc, Dept Immunobiol, Sendai, Miyagi, Japan

[4] Toyama Univ, Sch Med Sci, Dept Innovat Canc Immunotherapy, Toyama, Japan

[5] Toyama Univ, Grad Sch Med Pharm Sci, Dept Immunol, Toyama, Japan

[6] Kochi Univ, Dept Immunol, Kochi, Japan

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

J-1044

引用

页码：282 / 282

页数：1